Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Psychiatry Research|July 19, 2015
Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic reviewGuillaume Fond, Jean-Arthur Micoulaud-Franchi, Lore Brunel, et al.Neuroethics|October 17, 2025
A Moratorium on Implantable Non-Medical Neurotech Until Effects on the Mind are Properly UnderstoodChristoph Bublitz, Jennifer A Chandler, Fruzsina Molnár-Gábor, et al.Frontiers in Human Neuroscience|November 1, 2024
HYBRIDMINDS-summary and outlook of the 2023 international conference on the ethics and regulation of intelligent neuroprosthesesMaria Buthut, Georg Starke, Tugba Basaran Akmazoglu, et al.BMC Medical Ethics|August 13, 2024
Qualitative studies involving users of clinical neurotechnology: a scoping reviewGeorg Starke, Tugba Basaran Akmazoglu, Annalisa Colucci, et al.Frontiers in Public Health|February 26, 2021
A Central Clearing Clinic to Provide Mental Health Services for Refugees in GermanyMalek Bajbouj, Patricia Panneck, Sibylle-Maria Winter, et al.Journal of Neural Engineering|August 9, 2019
Brain-computer interfaces and personhood: interdisciplinary deliberations on neural technologyMatthew Sample, Marjorie Aunos, Stefanie Blain-Moraes, et al.Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|May 15, 2023
Minding Rights: Mapping Ethical and Legal Foundations of 'Neurorights'Sjors Ligthart, Marcello Ienca, Gerben Meynen, et al.Journal of Affective Disorders|March 25, 2026
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.Journal of Affective Disorders|December 20, 2024
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.Journal of Affective Disorders|February 5, 2023
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.Pageof 5